157 related articles for article (PubMed ID: 26586489)
1. Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations.
Kfoury AG; Miller DV; Snow GL; Afshar K; Stehlik J; Drakos SG; Budge D; Fang JC; Revelo MP; Alharethi RA; Gilbert EM; Caine WT; McKellar S; Molina KM; Hammond MEH
J Heart Lung Transplant; 2016 Mar; 35(3):335-341. PubMed ID: 26586489
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation.
Kfoury AG; Snow GL; Budge D; Alharethi RA; Stehlik J; Everitt MD; Miller DV; Drakos SG; Reid BB; Revelo MP; Gilbert EM; Selzman CH; Bader FM; Connelly JJ; Hammond ME
J Heart Lung Transplant; 2012 Jan; 31(1):46-51. PubMed ID: 22153551
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.
Kfoury AG; Hammond ME; Snow GL; Drakos SG; Stehlik J; Fisher PW; Reid BB; Everitt MD; Bader FM; Renlund DG
J Heart Lung Transplant; 2009 Aug; 28(8):781-4. PubMed ID: 19632573
[TBL] [Abstract][Full Text] [Related]
4. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
[TBL] [Abstract][Full Text] [Related]
5. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
[TBL] [Abstract][Full Text] [Related]
6. Early screening for antibody-mediated rejection in heart transplant recipients.
Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection.
Revelo MP; Miller DV; Stehlik J; Brunisholz K; Drakos S; Gilbert EM; Everitt M; Budge D; Alharethi R; Snow G; Hammond EH; Kfoury AG
Cardiovasc Pathol; 2012; 21(6):445-54. PubMed ID: 22381397
[TBL] [Abstract][Full Text] [Related]
8. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation.
Kfoury AG; Renlund DG; Snow GL; Stehlik J; Folsom JW; Fisher PW; Reid BB; Clayson SE; Gilbert EM; Everitt MD; Bader FM; Singhal AK; Hammond ME
J Heart Lung Transplant; 2009 Jan; 28(1):51-7. PubMed ID: 19134531
[TBL] [Abstract][Full Text] [Related]
9. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.
Hammond MEH; Revelo MP; Miller DV; Snow GL; Budge D; Stehlik J; Molina KM; Selzman CH; Drakos SG; Rami A A; Nativi-Nicolau JN; Reid BB; Kfoury AG
J Heart Lung Transplant; 2016 Mar; 35(3):320-325. PubMed ID: 26970471
[TBL] [Abstract][Full Text] [Related]
10. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
11. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.
Kfoury AG; Stehlik J; Renlund DG; Snow G; Seaman JT; Gilbert EM; Stringham JS; Long JW; Hammond ME
J Heart Lung Transplant; 2006 Nov; 25(11):1277-82. PubMed ID: 17097489
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the Quilty effect in endomyocardial biopsy of patients after heart transplantation - from cellular rejection to antibody-mediated rejection?
Szymanska S; Grajkowska W; Sobieszczanska-Malek M; Zielinski T; Pyzlak M; Pronicki M
Pol J Pathol; 2016; 67(3):216-220. PubMed ID: 28155969
[TBL] [Abstract][Full Text] [Related]
14. Pathologic diagnosis of antibody-mediated rejection in endomyocardial biopsy after heart transplantation based on renewed International Society for Heart and Lung Transplantation criteria.
Szymańska S; Grajkowska W; Pronicki M
Pol J Pathol; 2014 Oct; 65(3):176-81. PubMed ID: 25372414
[TBL] [Abstract][Full Text] [Related]
15. A multi-institutional evaluation of antibody-mediated rejection utilizing the Pediatric Heart Transplant Study database: Incidence, therapies and outcomes.
Thrush PT; Pahl E; Naftel DC; Pruitt E; Everitt MD; Missler H; Zangwill S; Burch M; Hoffman TM; Butts R; Mahle WT
J Heart Lung Transplant; 2016 Dec; 35(12):1497-1504. PubMed ID: 27431753
[TBL] [Abstract][Full Text] [Related]
16. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation.
Tible M; Loupy A; Vernerey D; Suberbielle C; Beuscart T; Cazes A; Guillemain R; Amrein C; Pezzella V; Fabiani JN; Nochy D; Hill G; Empana JP; Jouven X; Charron D; Bruneval P; Duong Van Huyen JP
J Heart Lung Transplant; 2013 Aug; 32(8):769-76. PubMed ID: 23856214
[TBL] [Abstract][Full Text] [Related]
17. Alteration of Cardiac Deformation in Acute Rejection in Pediatric Heart Transplant Recipients.
Chanana N; Van Dorn CS; Everitt MD; Weng HY; Miller DV; Menon SC
Pediatr Cardiol; 2017 Apr; 38(4):691-699. PubMed ID: 28161809
[TBL] [Abstract][Full Text] [Related]
18. Outcome of antibody-mediated rejection compared to acute cellular rejection after pediatric heart transplantation.
Vaughn GR; Jorgensen NW; Law YM; Albers EL; Hong BJ; Friedland-Little JM; Kemna MS
Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29222866
[TBL] [Abstract][Full Text] [Related]
19. Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy.
Heikal NM; Bader FM; Martins TB; Pavlov IY; Wilson AR; Barakat M; Stehlik J; Kfoury AG; Gilbert EM; Delgado JC; Hill HR
Transplant Proc; 2013; 45(1):376-82. PubMed ID: 23267802
[TBL] [Abstract][Full Text] [Related]
20. Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection.
Fedrigo M; Feltrin G; Poli F; Frigo AC; Benazzi E; Gambino A; Tona F; Caforio AL; Castellani C; Toscano G; Gerosa G; Thiene G; Angelini A
J Heart Lung Transplant; 2013 Apr; 32(4):404-9. PubMed ID: 23498161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
